The defection of PAPSS2 can lead to alarming bone development diseases, containing malformation, spondyloepimetaphyseal dysplasia, hepatocellular carcinoma, estrogenic hormone disorder, and so on (Zhang et al., 2022). This evidence concerns the gene PAPSS2 and hepatocellular carcinoma.